K J Sung, S E Chang, E M Paik, M W Lee, J H Choi
Index: Neuropeptides 33 , 435-446, (1999)
Full Text: HTML
It is well known that psoriasis, an immunogenetic cutaneous disorder whose major pathogenic findings are epidermal hyperplasia and T-cell infiltration, is aggravated by psychological stresses. Although the exact mechanism is not yet clarified, antidromic secretion of neuropeptides by cutaneous nerve fibers is thought to be involved. In this study, we examined the effect and mechanism of vasoactive intestinal polypeptide (VIP), one of the major neuropeptides, on the proliferation of HaCaT cell which is a spontaneous, immortalized, human keratinocyte cell line. Twenty-four and 48 h after its addition, 1 pM to 100 nM of VIP increased the number of cells cultured with/without serum. We indirectly verified VIP(1)R on the surface of HaCaT cell based on the proliferative ability of various VIP families such as VIP, PACAP and secretin, and increased PKA level 30 min after stimulation. However, because H-89, a PKA inhibitor, did not inhibit the proliferative potential of VIP, its mitogenicity is not medicated through VIP(1)R. One nM VIP produced the TGF-alpha protein which is a strong mitogen of keratinocytes and increased in the psoriatic lesion 2.25 times more compared with the control. Genistein, a tyrosine kinase inhibitor, abrogated the mitogenic activity of VIP. Like VIP, VIP fragments, VIP(1-12) and VIP(10-28) also acted as a mitogen for HaCaT cells through the same mechanism. Collectively, our studies clearly show that VIP and its fragments stimulate keratinocyte growth, not through increased cAMP level, but through increased TGF-alpha protein production.Copyright 1999 Harcourt Publishers Ltd.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
VIP (1-12), human, porcine, rat, ovine
CAS:120928-03-2 |
C61H88N18O22 |
The entire vasoactive intestinal polypeptide molecule is req...
1993-07-01 [J. Pharmacol. Exp. Ther. 266 , 392-399, (1993)] |
Mechanisms of vasodilation elicited by VIP in sterically sta...
1997-07-01 [Am. J. Physiol. 273 , R287-292, (1997)] |
Vasoactive intestinal peptide 1-12: a ligand for the CD4 (T4...
1987-01-01 [J. Neurosci. Res. 18 , 102, (1987)] |
Inhibitory effect of vasoactive intestinal peptide (VIP) on ...
1994-12-15 [Regul. Pept. 54 , 457-466, (1994)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved